Viewing StudyNCT03481998



Ignite Creation Date: 2024-05-06 @ 11:17 AM
Last Modification Date: 2024-10-26 @ 12:43 PM
Study NCT ID: NCT03481998
Status: COMPLETED
Last Update Posted: 2023-11-21
First Post: 2018-03-14

Brief Title: A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Sponsor: Jiangsu HengRui Medicine Co Ltd
Organization: Jiangsu HengRui Medicine Co Ltd

Conditions & Keywords Data

Conditions:
Name
Advanced Breast Cancer
Keywords:
Name View
CDK46 inhibitor View
Breast cancer View
Postmenopausal women View
Hormone-receptor positive View
HER2 negative View
Premenopausal women View